Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01196208
Title A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications

primary cutaneous T-cell non-Hodgkin lymphoma

Hodgkin's lymphoma

anaplastic large cell lymphoma

Therapies

Brentuximab vedotin

Age Groups: senior | adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | BEL


No variant requirements are available.